A SODIUM HYALURONATE OPHTHALMIC SOLUTION FOR REDUCING DRY EYE AND ENHANCING CORNEAL WOUND HEALING AFTER PHOTOREFRACTIVE KERATECTOMY (PRK)
Journal Title: Asian Journal of Pharamceutical and Clinical Research - Year 2015, Vol 8, Issue 2
Abstract
 Objective: The objective of this work was to evaluate the efficacy and safety of 0.3% sodium hyaluronate (SH) versus hydroxypropyl-methylcellulose(HPMC)/dextran in reducing dry eye symptoms, recovering tear film function and enhancing corneal wound healing in patients who underwentphotorefractive keratectomy (PRK) surgery.Methods: This was a randomized, masked-assessor, controlled, parallel-group and Phase II trial. 24 patients received 1 drop of 0.3% SH or HPMC/dextran into each eye every 2 hrs during the first month after surgery, then as needed until the day (D) 168. Efficacy and safety criteria were assessedduring six follow-up visits (D1, D3, D7, D28, D84 and D168).Results: About 0.3% SH caused a greater improvement than control in half of the efficacy criteria, including symptoms intensity and frequency,comfort of the eye drops, corneal haze, Schirmer I test, fluorescein and rose Bengal staining. At D28 and D84, a statistically significant differencefavoring 0.3% SH was demonstrated for fluorescein corneal staining (p=0.0114 and p=0.0308, respectively). At D3, completed re-epithelization of thecornea was observed, 98% and 96% in 0.3% SH and control group respectively. The overall results for each of the measures used to assess the safetyindicated that 0.3% SH had an excellent safety profile over 168 days of treatment.Conclusion: About 0.3% SH is a safe and effective treatment in reducing dry eye and enhancing corneal epithelial wound healing after PRK surgery.Keywords: Dry eye, Artificial tears, Sodium hyaluronate, Ocular lubricants, Refractive surgery, Photorefractive keratectomy.
Authors and Affiliations
Ngamjit Kasetsuwan, Usanee Reinprayoon
Keywords
Related Articles
- EP ID EP605674
- DOI -
- Views 112
- Downloads 0
PHYSICAL, CHEMICAL CHARACTERISTICS AND RELEASE RATE OF MELOXICAM FROM NANOSTRUCTURED LIPID CARRIERS (NLC) SYSTEM USING SOME CONCENTRATION RATIOS OF MONOSTEARIN AND ALPHA TOCOPHEROL ACETATE LIPID MATRIX
Objective: The objective of this research is to develop nanostructured lipid carriers (NLC) of meloxicam (MLX) for topical application using monostearin and alpha-tocopherol as lipid matrix.Methods: MLX-NLC was prepared...
SPONTANEOUS ADVERSE DRUG REACTION REPORTING IN A TERTIARY CARE HOSPITAL IN CALICUT
Objective: The study was conducted to assess the adverse drug reactions (ADRs) reported in a tertiary care hospital in Calicut.Methods: Spontaneous ADR reporting method was followed for the study. The ADRs reported by th...
ISOLATION OF SOME POTENTIAL PHYTOCOMPOUNDS FROM ADHATODA VASICA THROUGH GAS CHROMATOGRAPHY-MASS SPECTROSCOPY ANALYSIS
  Objective: The aim of this study is to screen the medicinal compounds present in the leaves, shoots, and flowers of Adhatoda vasica by gas chromatography-mass spectroscopy (GC-MS) analysis. Methods: Plant leaves, sho...
THE POTENTIAL BENEFIT AND THE MECHANISM OF ACTION OF THYROXINE ON SERUM LIPIDS AND BLOOD FLOW INDEXES IN SUBCLINICAL HYPOTHYROIDISM WOMEN
Objective: Even previous reports mentioned that thyroxine has beneficial effects on subclinical hypothyroidism (SCH); however, the mechanism by which thyroxine mediated such effect still unclear. Thus, we aim to find out...
PULSATILE DRUG DELIVERY SYSTEMS: A CASE OF BETA-BLOCKERS
The diseases involve heart and blood vessels are classified under cardiovascular diseases. Hypertension (HTN) is a disorder of the CV system characterized by elevated arterial blood pressure. Pulsatile drug delivery syst...